25-NSE: Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities (and amendment thereto)
Apr 25 21:15
8-K: Current report
Apr 17 21:14
Acorda Therapeutics | 8-K: Current report
Apr 5 01:02
Acorda Therapeutics | 8-K: Current report
Apr 3 01:05
Acorda Therapeutics | 10-K: Annual report
Apr 2 05:12
Acorda Therapeutics | 8-K: Current report
Mar 14 04:39
Acorda Therapeutics | 8-K: Current report
Jan 11 13:00
Acorda Therapeutics | 8-K: Current report
Dec 2, 2023 05:30
Acorda Therapeutics: Q3 2023 Earnings Report
Nov 14, 2023 09:41
Acorda Therapeutics | 8-K: Current report
Nov 14, 2023 05:16
Acorda Therapeutics | 10-Q: Q2 2023 Earnings Report
Aug 9, 2023 05:36
Acorda Therapeutics | 8-K: Current report
Aug 9, 2023 04:12
Acorda Therapeutics | 8-K: Current report
Jun 28, 2023 04:35
Acorda Therapeutics | 8-K: Current report
Jun 27, 2023 04:30
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director BURNS THOMAS M.
Jun 24, 2023 07:59
Acorda Therapeutics | 3: Initial statement of beneficial ownership of securities-Director BURNS THOMAS M.
Jun 24, 2023 07:57
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Varian John
Jun 24, 2023 05:38
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director PANEM SANDRA PHD
Jun 24, 2023 05:37
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Kelley John P
Jun 24, 2023 05:36
Acorda Therapeutics | 4: Statement of changes in beneficial ownership of securities-Director Jensen Peder
Jun 24, 2023 05:34
No Data
No Data